News Archive

A wide range of stakeholders who attended an April 2019 DCRI Think Tank helped to identify current challenges to developing treatments for chronic kidney disease, as well as make recommendations for strategies to address these challenges.

Since its inception in 2015, the CARRA Registry, for which the DCRI serves as the coordinating center, has provided necessary infrastructure and data to support a wide range of clinical research projects.

Even in the midst of a global pandemic, taking the time to conduct randomized controlled trials is the most rigorous way to build evidence for potential treatments, according to a recent opinion pi

As the proliferation of real-world data continues, it is important to refocus on combining randomized trials with real-world data sources rather than relying on observations or common sense, write

A multi-disciplinary scientific advisory board will provide rapid readouts of data on epidemiology, infection transmission rates, and other research. The pilot project, which is funded by the NIH, creates a model with potential to expand to additional school districts across the nation.

Attendees to a January 2019 DCRI Think Tank outlined recommendations for optimizing pragmatic clinical trials and weighing risks and benefits of innovative trial designs.

An analysis of a study called Mission: Lifeline STEMI Accelerator II found that when patients experiencing an ST-elevation myocardial infarction present in facilities not capable of performing percutaneous intervention, the time between their arrival and cath lab activation is an important quality metric to direct timely reperfusion.

DCRI faculty recently contributed to a paper advocating for a focus on pain management so that progress in combatting the U.S. opioid crisis is not lost in the midst of the COVID-19 pandemic.

Study results recently published in the Journal of the American College of Cardiology: Heart Failure build on novel research investigating the efficacy of blocking the splanchnic nerve to treat patients with heart failure. The study, which was led by former DCRI fellow Marat Fudim, MD, MHS, included 15 patients who underwent a temporary medication-induced splanchnic nerve blockage and required them to complete an exercise twice—once prior to the blockage, and once after the blockage.

Although valve failure is rare, patients who had to undergo re-operation were at risk of negative outcomes.